“…Beyond CID-based implementation of tethered probes, 13 , 27 , 28 recent examples in the first subclass include proteasome targeting, 29 , 30 T cell activity control, 31 antibody recruitment, 9 , 32 and development of hybrid pharmaceuticals. 33 , 34 The second subclass is represented by multifunctional small-molecule-derived conjugates that function as potent and specific inhibitors, 35 , 36 biosensors, 37 , 38 reporters, 10 , 39 , 40 and protein-activity modulators. 41 , 42 …”